At the news
? NEUTRALIMPACT 3/10 EFFECT filed Nov 12, 2026 at 00:15 ET
Ping An Biomedical Co., Ltd. received SEC effectiveness on November 10, 2026 for its shelf registration on Form F-3 (File No. 333-299624). The company can now offer and sell securities at any time, creating potential dilution overhang for the micro-cap stock ($4M market cap).
- Effectiveness date: November 10, 2026
- Registration statement type: F-3 (shelf registration for foreign private issuers)
- SEC File Number: 333-299624
- Company market cap: $4M
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access